semaglutide and crohn's Disease: Safety, Risks, and What Patients Should Know Semaglutide & Crohn's Disease: Safety
Description
Preclinical models indicate that stimulating intestinal BTRs has the potential to improve blood glucose control
Fiber does not act like a drug version of GLP-1
Future generations of incretin agonists may be able to maintain the reduction in blood glucose and body weight while minimizing these off-target effects
We recognize that true wellness encompasses both physical and mental well-being
